XML 18 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Dec. 30, 2017
Dec. 31, 2016
Cash flows from operating activities:    
Net income $ 121.5 $ 104.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 219.4 231.9
Deferred income tax expense (benefit) (8.0) 9.8
Equity in losses of equity-method investees 3.6 5.2
Non-cash stock-based compensation expense 56.3 46.4
Non-cash impairment of assets 24.8 56.7
Non-cash restructuring-related inventory charges 1.3 149.4
Other non-cash charges 6.7 18.1
Changes in operating assets and liabilities:    
Accounts receivable 158.9 214.9
Inventories (11.6) (36.5)
Prepaid expenses and other current assets (4.2) (72.8)
Accounts payable and accrued liabilities 105.0 98.4
Income tax receivables and payables 279.7 (2.6)
Deferred income 3.8 (15.5)
Other balance sheet changes (6.1) 42.6
Net cash provided by operating activities 951.1 850.7
Cash flows from investing activities:    
Capital expenditures (123.0) (225.5)
Purchases of investments (985.5) (460.5)
Proceeds from sales and maturities of investments 795.3 704.8
Acquisitions and ventures (4.6) (2.5)
Net cash provided by (used in) investing activities (317.8) 16.3
Cash flows from financing activities:    
Proceeds from issuance of short-term debt 0.0 3,735.2
Repayments of short-term debt 0.0 (3,851.3)
Payments of capital lease obligations (21.2) (19.4)
Payments of dividends (121.7) (123.7)
Repurchases of common stock, including shares surrendered for tax withholdings (15.9) (115.0)
Proceeds from exercises of stock options 0.1 4.7
Net cash used in financing activities (158.7) (369.5)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 36.8 (29.0)
Net increase in cash, cash equivalents, and restricted cash 511.4 468.5
Cash, cash equivalents, and restricted cash at beginning of period 711.8 502.1
Cash, cash equivalents, and restricted cash at end of period $ 1,223.2 $ 970.6